Qiu et al. demonstrated that miR-429 could suppresses cell proliferation, EMT, and metastasis by directly targeting of BMI1 and E2F3 in renal cell carcinoma [32]. This evidence concerns the gene E2F3 and hereditary clear cell renal cell carcinoma.